1. Albores-Saavedra, J., Gersell, D., Gilks, C. B., Henson, D. E., Lindberg, G., Santiago, H., Scully, R. E., Silva, E., Sobin, L. H., Tavassoli, F. J., Travis, W. D., & Woodruff, J. M. (1997). Terminology of endocrine tumors of the uterine cervix: Results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Archives of Pathology & Laboratory Medicine, 121(1), 34–39.
2. Alejo, M., Alemany, L., Clavero, O., Quiros, B., Vighi, S., Seoud, M., Cheng-Yang, C., Garland, S. M., Juanpere, N., Lloreta, J., Tous, S., Klaustermeier, J. E., Quint, W., Bosch, F. X., de Sanjosé, S., Lloveras, B., & RIS HPV TT Study Group. (2018). Contribution of human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases. Papillomavirus Research (Amsterdam, Netherlands), 5, 134–142. https://doi.org/10.1016/j.pvr.2018.03.005.
3. Alvarado-Cabrero, I., Euscher, E. D., Ganesan, R., & Howitt, B. E. (2020). Small cell neuroendocrine carcinoma. In The WHO Classification of Tumours Editorial Board (Ed.), Female genital tumours 5th edition; vol.4, Lyon (France).
4. Basu, B., Sirohi, B., & Corrie, P. (2010). Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin. Endocrine-Related Cancer, 17(1), R75–R90. https://doi.org/10.1677/ERC-09-0108.
5. Bosman, F. T., Carneiro, F., Hruban, R. H., & Theise, N. D. (2010). World Health, Organization (WHO) classification of tumours of the digestive system (4th ed.). Geneva: WHO Press. [Google Scholar].